Radionuclide therapy of HER2-expressing human xenografts using an affibody molecule-based PNA-mediated pretargeting: in vivo proof-of-principle. (Q50036592)
Jump to navigation
Jump to search
scientific article published on 9 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Radionuclide therapy of HER2-expressing human xenografts using an affibody molecule-based PNA-mediated pretargeting: in vivo proof-of-principle. |
scientific article published on 9 February 2018 |
Statements
1 reference
Radionuclide therapy of HER2-expressing human xenografts using an affibody molecule-based PNA-mediated pretargeting: in vivo proof-of-principle. (English)
1 reference
Kristina Westerlund
Mohamed Altai
Bogdan Mitran
Mark Konijnenberg
Christina Atterby
Marion de Jong
Patrick Micke
Amelie Eriksson Karlström
Vladimir Tolmachev
9 February 2018
1 reference